Oct 2026
B-168 Purified Recombinant Human Albumin Produced in Thermothelomyces heterothallica (C1) Demonstrates Effective Blocking and Comparable Surface Binding to Other Recombinant and Native Albumins
Findings support C1-derived rHA as a reliable alternative for surface blocking and coating applications, offering comparable performance while reducing variability and production cost limitations associated with existing albumin products.
Audrianna Kern, A. Okerlund, C. Kunkler et al.
· Clinical Chemistry · 0 citations